Longyi Zeng

Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial

Jianping Weng, Yanbing Li, Wen Xu et al. · The Lancet · 2008 · 761 citations

Insulin Resistance, Diabetes Management, Parallel-group Trial +6

Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease

Jinhua Yan, Bin Yao, Hongyu Kuang et al. · Hepatology · 2018 · 242 citations · Full text

Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study

Dalong Zhu, Shenglian Gan, Yu Liu et al. · The Lancet Diabetes & Endocrinology · 2018 · 97 citations

Dorzagliatin Monotherapy, Diabetes Management, Medicine +7

Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial

Dalong Zhu, Jianhua Ma, Jiao’e Zeng et al. · Nature Medicine · 2022 · 87 citations · Full text

Metabolic Syndrome, Diabetes Management, Placebo-controlled Phase 3 +8

High Prevalence of Coronary Heart Disease in Type 2 Diabetic Patients with Non-alcoholic Fatty Liver Disease

Hongyun Lu, Longyi Zeng, Biao Liang et al. · Archives of Medical Research · 2009 · 72 citations

Fatty Liver Disease, Metabolic Syndrome, Diabetes Epidemiology +17